Home Risk Management/Safety Two-thirds of neurologists expect to start some patients on Aduhelm next year: survey Two-thirds of neurologists expect to start some patients on Aduhelm next year: surveyadmin Sep 17, 2021 0 Comments Two-thirds of neurologists surveyed early this month said that they expect to have some patients started on the new Alzheimer’s disease drug aducanumab (Aduhelm) by March 2022.
